Research Interests

  • Noninvasive
  • Medical Devices
  • Hyperspectral
  • Fluorescence

Biography

  • Attending Physician, Pediatric Surgery
  • Director, Surgical Simulation Program
  • Program Director, Fellowship in Pediatric Surgery
  • Associate Professor of Surgery (Pediatric General Surgery), Northwestern University Feinberg School of Medicine

See Lurie Children's Provider Profile

Dr. Goldstein practices pediatric general and thoracic surgery, as well as pediatric surgical oncology. He treats newborns, infants and children with a wide range of conditions, including congenital and acquired diseases. He has particular expertise with chest wall deformities, vascular and lymphatic malformations, and foregut disorders of the esophagus, stomach, and pancreas. He is comfortable with both traditional and minimally invasive approaches, including laparoscopic inguinal hernia repairs. 
 
In addition to extraordinary enthusiasm for patient care, Dr. Goldstein is a surgeon-scientist. He has authored over 100 peer-reviewed journal publications and 10 book chapters. His funded research endeavors leverage his graduate work and industry background in biomedical engineering to devise and develop technologies that benefit children. Additionally, he is an accomplished health services researcher and is widely recognized as a national expert in areas of pediatric surgical quality and safety.

Education and Background

  • Fellowship in Pediatric Surgery, Johns Hopkins Hospital and University of Maryland Medical Center 2016-2018
  • Residency in General Surgery, Johns Hopkins Hospital Department of Surgery 2009-2016
  • MD, Johns Hopkins University School of Medicine 2009

Research Highlights

NONINVASIVE IDENTIFICATION OF NEONATAL ISCHEMIA USING BROADBAND OPTICAL SPECTROSCOPY

In a first-in-human trial, we are pioneering the application of a newly developed noninvasive infrared light reflectance technology known as broadband optical spectroscopy (BOS) as a method of identifying neonatal ischemia. BOS leverages the fact the cellular byproducts of ischemia are dark chromophores that absorb both visible and infrared light to take a measurement of internal organs through skin in order to detect the onset of diseases such as necrotizing enterocolitis and hypoxic ischemic encephalopathy.